Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Moleculin Biotech, Inc. | a2019q410-kexhibit322x.htm |
| EX-32.1 - EX-32.1 - Moleculin Biotech, Inc. | a2019q410-kexhibit321x.htm |
| EX-31.2 - EX-31.2 - Moleculin Biotech, Inc. | a2019q410-kexhibit312x.htm |
| EX-31.1 - EX-31.1 - Moleculin Biotech, Inc. | a2019q410-kexhibit311x.htm |
| EX-10.26 - EX-10.26 - Moleculin Biotech, Inc. | a2019q410-kexh1026saba.htm |
| EX-10.25 - EX-10.25 - Moleculin Biotech, Inc. | a2019q410-kexh1025hpie.htm |
| EX-10.24 - EX-10.24 - Moleculin Biotech, Inc. | a2019q410-kexh1024cons.htm |
| 10-K - 10-K - Moleculin Biotech, Inc. | mbx-20191231.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 19, 2020, with respect to the consolidated financial statements included in the Annual Report of Moleculin Biotech, Inc. on Form10-K for the year ended December 31, 2019. We consent to the incorporation by reference of said reports in the Registration Statements of Moleculin Biotech, Inc. on Forms S-1 (File No. 333-214898, File No. 333-215974, File No. 333-224243, File No. 333-226146 and File No. 333-227845), Form S-3 (File No. 333-219434) and on Forms S-8 (File No. 333-212619 and File No. 333-225867).
/s/ GRANT THORNTON LLP
Houston, Texas
March 19, 2020